Welcome to LookChem.com Sign In|Join Free

CAS

  • or
2-[3-[3-(Trifluoromethyl)phenyl]ureido]benzoic acid is a chemical compound with the molecular formula C16H12F3NO3. It is a derivative of benzoic acid and contains a trifluoromethylphenyl group and a ureido group. 2-[3-[3-(Trifluoromethyl)phenyl]ureido]benzoic acid is often used in research and pharmaceutical applications due to its potential biological activities.

1566-81-0

Post Buying Request

1566-81-0 Suppliers

Recommended suppliersmore

  • Product
  • FOB Price
  • Min.Order
  • Supply Ability
  • Supplier
  • Contact Supplier

1566-81-0 Usage

Uses

Used in Pharmaceutical Research:
2-[3-[3-(Trifluoromethyl)phenyl]ureido]benzoic acid is used as a research compound for exploring its potential biological activities. It may have anti-inflammatory, analgesic, or antipyretic properties and has shown activity against certain enzymes and receptors in the body.
Used in Drug Development:
2-[3-[3-(Trifluoromethyl)phenyl]ureido]benzoic acid is used as a lead compound in drug development. Its potential biological activities and interactions with enzymes and receptors make it a promising candidate for the development of new medications.
Used in Medical Research:
2-[3-[3-(Trifluoromethyl)phenyl]ureido]benzoic acid is used as a subject of study in medical research to better understand its mechanisms of action and potential applications in treating various conditions. The precise mechanisms and applications of 2-[3-[3-(Trifluoromethyl)phenyl]ureido]benzoic acid are still being studied, but it holds promise for future advancements in the medical field.

Check Digit Verification of cas no

The CAS Registry Mumber 1566-81-0 includes 7 digits separated into 3 groups by hyphens. The first part of the number,starting from the left, has 4 digits, 1,5,6 and 6 respectively; the second part has 2 digits, 8 and 1 respectively.
Calculate Digit Verification of CAS Registry Number 1566-81:
(6*1)+(5*5)+(4*6)+(3*6)+(2*8)+(1*1)=90
90 % 10 = 0
So 1566-81-0 is a valid CAS Registry Number.

1566-81-0Downstream Products

1566-81-0Relevant articles and documents

COMPOUNDS AND METHODS FOR INDUCING CHONDROGENESIS

-

Paragraph 0778, (2014/09/29)

Described herein are compounds and compositions for the amelioration of arthritis or joint injuries by inducing mesenchymal stem cells into chondrocytes.

Substituted phenyl derivatives, their preparation and use

-

, (2008/06/13)

The present invention discloses compounds having the formula wherein the substituents are defined in the application. The compounds are useful as chloride channel blockers.

2-Arylureidobenzoic Acids: Selective Noncompetitive Antagonists for the Homomeric Kainate Receptor Subtype GluR5

Valgeirsson, Jon,Nielsen, Elsebet ?.,Peters, Dan,Varming, Thomas,Mathiesen, Claus,Kristensen, Anders S.,Madsen, Ulf

, p. 5834 - 5843 (2007/10/03)

A series of 2-arylureidobenzoic acids (AUBAs) was prepared by a short and effective synthesis, and the pharmacological activity at glutamate receptors was evaluated in vitro and in vivo. The compounds showed noncompetitive antagonistic activity at the kainate receptor subtype GluR5. The most potent compounds showed more than 50-fold selectivity for GluR5 compared to GluR6 and the AMPA receptor subtypes GluR1-4. The structure-activity relationships for the AUBAs showed distinct structural requirements for the substituents on the two aromatic ring systems. Only para-substituents were tolerated on the benzoic acid moiety (ring A), whereas ring B tolerated a variety of substituents, but with a preference for lipophilic substituents. The most potent compounds had a 4-chloro substituent on ring A and 3-chlorobenzene (6b), 2-naphthalene (8h), or 2-indole (8k) as ring B and had IC50 values of 1.3, 1.2, and 1.2 μM, respectively, in a functional GluR5 assay. Compound 6c (IC50 = 4.8 μM at GluR5) showed activity in the in vivo ATPA rigidity test, indicating that 6c has better pharmacokinetic properties than 8h, which was inactive in this test. The AUBAs are the first example of a series of noncompetitive GluR5-selective antagonists and may prove to be important pharmacological tools and leads in the search for therapeutic glutamatergic agents.

Substituted phenyl derivatives, their preparation and use

-

, (2008/06/13)

The present invention discloses compounds having the formula wherein the substituents are defined in the application. The compounds are useful as chloride channel blockers.

Synthesis and evaluation of inhibitors of transthyretin amyloid formation based on the non-steroidal anti-inflammatory drug, flufenamic acid

Baures, Paul W.,Oza, Vibha B.,Peterson, Scott A.,Kelly, Jeffery W.

, p. 1339 - 1347 (2007/10/03)

A light scattering-based amyloid fibril formation assay was employed to evaluate potential inhibitors of transthyretin (TTR) amyloid fibril formation in vitro. Twenty nine aromatic small molecules, some with homology to flufenamic acid (a known non-steroidal anti-inflammatory drug) were tested to identify important structural features for inhibitor efficacy. The results of these experiments and earlier data suggest that likely inhibitors will have aromatic-based structures with at least two aromatic rings. The ring or fused ring system occupying the outermost TTR binding pocket needs to be substituted with an acidic functional group (e.g. a carboxylic acid) to interact with complimentary charges in the TTR binding site. The promising TTR amyloid fibril inhibitors ranked in order of efficacy are: 2>4~7>3>9>6>21 (see Structural summary of the best transthyretin amyloid fibril formation inhibitors identified in this study. The order of efficacy is: 2>4~7>3>9>6>21.). Copyright (C) 1999 Elsevier Science Ltd.

Post a RFQ

Enter 15 to 2000 letters.Word count: 0 letters

Attach files(File Format: Jpeg, Jpg, Gif, Png, PDF, PPT, Zip, Rar,Word or Excel Maximum File Size: 3MB)

1

What can I do for you?
Get Best Price

Get Best Price for 1566-81-0